🎪 Trump, Marijuana Rescheduling, And The Schedule 3 Circus

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today we are watching a possible Schedule 3 move out of the White House, Ohio’s decision to tighten a voter-approved mandate, and New York’s scramble to stand up Metrc without crushing small operators. Together they sketch who might get real tax relief, who absorbs the brunt of the hemp crackdown, and which markets will be asked to grow up fastest before voters head back to the polls.

Today’s edition is supported by You.com, Fisher Investments, and Superhuman AI. If you want your work in front of the same decision-makers, reply to this email and we will talk about sponsoring a future edition.

🎪 Schedule 3, 280E, and election-year politics
🧭 States tightening marijuana, hemp, and tracking rules
🌍 Imports, aging consumers, and shifting demand

Enjoy the weekend; we will be back in your inbox on Monday.

📌 What Happened: The Washington Post reports that President Trump is preparing an executive order directing federal agencies to reclassify marijuana to Schedule 3, leaning on the stalled Biden-era rescheduling work rather than starting from scratch. The idea surfaced during an Oval Office discussion with Speaker Mike Johnson, Health Secretary Robert F. Kennedy Jr., CMS chief Mehmet Oz, and several industry executives, where Johnson argued against rescheduling and the executives pushed hard in the other direction. An order along these lines would tell DOJ and DEA to finish the existing rule, skip a lengthy evidentiary hearing, and move cannabis into the same schedule as many prescription drugs while keeping it illegal under the Controlled Substances Act. The White House is still telling reporters that no final call has been made, even as prohibitionist groups raise money off warnings that an announcement could land at any time. A move to Schedule 3 would not change basic criminal penalties overnight, yet it would ease research barriers and remove Section 280E from state-licensed cannabis businesses, which is the single biggest federal tax shift they have ever been offered.

💡 Why It Matters: Schedule 3 is a narrow fix with wide consequences. Ending 280E for licensed cannabis operators dramatically changes the math on margins, valuations, and consolidation, even if nothing else in federal law catches up right away. Treasury, bank counsel, and public company boards will all start asking whether the combination of state licensing and Schedule 3 is enough to revisit old red lines on lending and listing. The move also hands the Supreme Court an easy way to stay out of the broadest cannabis cases for now, including a live challenge to federal prohibition and several 280E fights that rest on marijuana’s place in the schedule table, because the political branches can argue that they are finally adjusting the system themselves. Politically, Republicans get a chance to say they modernized cannabis policy, delivered a business-side tax win, and kept full legalization off the table, which is a useful message to carry into 2026 if they don’t fumble the rollout and time it well. It also claims the issue from Democrats and may cater to seniors, veterans and other traditionally conservative voter blocs. All of this plays out against the new federal hemp ban and a wave of crackdowns on intoxicating hemp, which makes it easier for Washington to treat hemp THC as the expendable piece and state-regulated cannabis as the part of the market worth normalizing.

🚔 Ohio Rewrites Voter Legalization While Racing Its Own Hemp Ban

Gov. Mike DeWine says he will sign a recently enacted legislative package that keeps the basic possession limits from the 2023 voter-approved ballot question on paper while adding public-use rules, open-container style offenses for cannabis outside original packaging, landlord and venue veto power, and new minor misdemeanors for conduct many voters assumed was legal. The bill weakens civil protections from the ballot measure, including language around employment, housing, custody, and professional licensing, and walks back a dedicated fund for expungement support. On the hemp side, products with more than trace THC or containing synthetics are pushed into the regulated marijuana system within months, while a temporary lane lets low-dose cannabinoid drinks stay in broader retail until the end of 2026. DeWine is already framing the package as a way to keep “juiced up” hemp gummies away from kids at gas stations, even as it builds a denser map of tripwires for consumers and a narrower lane for small hemp businesses. The deeper question for a purple-red state like Ohio is whether this hybrid model becomes a quiet template for federal and state copycats or a case study in how quickly a ballot-box win can be tightened in implementation. (Columbus Dispatch)

🛣️ Ohio’s Marijuana Billboard Ban Runs Into First Amendment Trouble

A First Amendment attorney in Cleveland.com argues that Ohio’s new marijuana billboard ban is unlikely to survive constitutional scrutiny, even though lawmakers package it as child protection. The rule would bar dispensaries from using off-premise billboards and highway signs while the same corridors stay open to alcohol, lottery, and casino ads. That kind of content-based line inside commercial speech triggers the Central Hudson test and asks courts to justify why one lawful product is gagged while others stay visible. The column points legislators toward time, place, and manner limits or packaging standards if they truly want to reduce youth exposure without stepping on the First Amendment. If lawmakers push ahead anyway, the likely endgame is a test case from a dispensary or advertising firm asking a federal judge why beer sales deserve more speech than cannabis on the same stretch of highway. (Cleveland.com)

🌾 Kentucky Column Turns Hemp Ban Into A Home-State Fight

Jim Higdon, the Cornbread Hemp co-founder who has been one of the most vocal hemp beverage operators through the shutdown fight and its aftermath, used a Courier Journal op-ed to argue that Congress “attacked Kentucky hemp” when it tucked a sweeping THC restriction into the funding deal while leaving synthetic knockoffs largely unaddressed. He frames the provision as a hit on compliant farmers and brands that built under the 2018 Farm Bill, while the worst actors keep operating in the gray. The column lands in the middle of Kentucky’s own family feud over hemp, with Mitch McConnell and Rand Paul pulling in different directions on what “fixing” hemp should look like and who takes the blame for the loophole economy. That matters because Higdon is not an abstract commentator, he is a Kentucky operator with name recognition and skin in the game, which gives lawmakers less room to dismiss this as online noise. If the state’s delegation moves at all, the pressure will come from voices like this one, rooted in Kentucky’s hemp identity and loud enough to force a response. (Courier Journal)

🍺 Chicago Tweaks Hemp Ban To Spare THC Drinks

Chicago’s proposed hemp-derived THC ban now includes an exemption for THC drinks after weeks of pressure from local breweries and bars that use low-dose beverages to keep taprooms busy. Earlier drafts from Ald. Marty Quinn would have swept those drinks in with vapes and gummies, prompting public campaigns and meetings where brewers warned the city it was about to erase a legal category they rely on. The carveout keeps hemp beverages on menus while most other hemp-derived THC products remain squarely in the ordinance’s sights. That approach fits a broader pattern in which lawmakers tolerate age-gated drinks while treating convenience-store edibles as the political and enforcement problem. What matters now is how the full council writes the enforcement mechanics and penalties, because that fine print will decide whether this is a narrow carveout that businesses can live with or a temporary reprieve that collapses under real-world implementation. (Block Club Chicago)

🕵️‍♂️ GOP Drug Caucus Tries To Pin Cartels On State Legalization

Sen. John Cornyn used a Senate Caucus on International Narcotics Control hearing on Chinese organized crime to fold state cannabis legalization into a wider cartel narrative. He and former DEA operations chief Ray Donovan pointed to Chinese and Mexican groups backing unlicensed grow houses in states like Maine and Oklahoma, with Donovan calling black market production “through the roof” and urging DOJ to make these cases a strategic priority. The testimony leans on real problems with foreign-financed grows while largely skipping over how federal prohibition keeps the market in cash, shadows, and lightly supervised intermediaries. The hearing also hands prohibitionist outfits like Smart Approaches to Marijuana fresh clips they can use to argue that rescheduling or federal reform would “empower Chinese cartels.” If that framing hardens, it will give future administrations cover for enforcement sweeps that catch compliant operators in the same dragnet as the actors DOJ says it wants to chase. (Marijuana Moment)

⚖️ Study Finds Cannabis Regulators Outperform Alcohol On Public Health

State cannabis agencies talk about public health far more than alcohol regulators do, according to a government-funded University of Maryland study that parsed annual reports in all 24 adult-use states. Researchers found that 68 percent of cannabis agencies referenced public health goals in their mission statements, compared with 35 percent of alcohol regulators, and cannabis agencies reported more work with health data and prevention programs. Alcohol regulators leaned more heavily on law enforcement language even in states that legalized both markets. The study also notes that states which legalized through their legislatures report richer public health work for both cannabis and alcohol than states that relied on ballot measures, hinting at a quieter maturation pattern in later-wave adopters. The findings undercut “regulate cannabis like alcohol” slogans and suggest that in practice, cannabis regulators already run the tighter public health ship. (Leafie)

☕ Massachusetts Finally Approves Rules For Cannabis Cafes

The Massachusetts Cannabis Control Commission has unanimously approved regulations for social consumption, clearing the way for the first regulated cannabis cafes and lounges in New England. The rules create three license types, including supplemental licenses for existing cannabis businesses, hospitality licenses for non-cannabis venues like yoga studios and theaters, and event organizer licenses for festivals and pop-ups where adults can legally consume on site. Venues cannot serve alcohol or tobacco and must meet safety requirements that include staff training, transportation plans, and access to food and non-alcoholic beverages so the sites feel like real hospitality rather than improvised smoking rooms. The first wave of licenses is reserved for participants in the commission’s social equity programs, microbusinesses, and craft cooperatives, which ties years of equity promises to a long-delayed category that some operators already built out space for. Massachusetts now joins a small group of states with formal consumption venues, although nothing opens until cities and towns opt in and a commission with a reputation for slow implementation proves it can move applications fast enough to matter. (Boston Globe)

🩺 Alabama Finally Awards First Medical Dispensary Licenses

The Alabama Medical Cannabis Commission has approved the state’s first four dispensary licenses, a vote commissioners are calling a milestone after years of lawsuits and do-overs. The move follows an administrative law judge’s recommended order on which applicants were “most suitable” and comes after repeated license rescissions over scoring problems, open-meetings claims, and broader challenges to how the commission picked winners. Executive Director John McMillan now estimates products could reach patients in two to three months once fees are paid and site inspections are finished, which puts a real clock on a program lawmakers passed back in 2021. Growers and processors who have been frozen in place finally have a plausible market to ship into, even as separate disputes over integrated licenses remain unresolved and likely headed for more litigation. The next signal will be whether Alabama can move from paper licenses to open doors on something close to that timeline or whether this “milestone” becomes one more date in a long story of delay. (Rocket City Now)

💸 Humboldt Lawsuit Puts Distributor Non-Payment Back Under The Microscope

A new lawsuit out of Humboldt County lays out a familiar nightmare for small growers: product leaves the farm with a Metrc manifest, deal sheet, and invoice, then the distributor stops paying and quietly shifts into a new license shell. H1 Canyon says Trusty Transportation took more than $117,000 in product, made one installment, then let the original license die while a new “Trusty Partnership” surfaced on paper. Local growers and HCGA leadership describe non-payment as a persistent structural problem rather than a one-off bad actor, with thin margins, retailer non-payment, and slow, fragmented DCC enforcement all layered together. Calls for broader self-distribution authority surface again in the story, framed as a survival tool for farms that cannot afford to bankroll the entire supply chain on trust. The line that “compliance is mandatory and payment is optional” explains why more of these disputes are moving from association back rooms into courtrooms. (Redheaded Blackbelt)

📋 New York Eases Metrc Deadline For Retailers, Keeps Clock Ticking For Everyone Else

New York pushed back the deadline for retailers to enter existing inventory into Metrc until January 12th, while keeping the system’s launch date set for December 17th. Retailers still need Metrc credentials by the 17th, and product arriving after that date cannot be sold unless it is properly entered and tracked, which keeps real pressure on the holiday stretch. The phased approach reads like a concession to small operators who already spent time and money integrating BioTrack before the Metrc acquisition flipped the plan. It also lands amid leadership churn at OCM, which raises the stakes for how the agency uses compliance power in its first weeks on the new platform. What matters, at this point, is that New York sticks the rollout landing. They need the win, and their program needs to move beyond rollout and into maturity. (Spectrum News 1)

🌍 Germany’s Medical Imports Turn Into A 600-Ton Signal

Germany’s medical cannabis program is quietly turning into one of the largest flower import markets on the planet, with industry executives now projecting a sprint toward 600 tons a year. Recent data show imports already tracking around 200 tons, driven largely by Canadian supply, with Portugal and Denmark filling in the middle and a long tail of smaller European producers chasing pharmacy shelf space. Telemedicine and CanG reforms have expanded the prescribing base enough that old volume caps were blown through and then raised, which tells regulators and exporters that demand has real legs. Domestic cultivation remains a rounding error, with only three German producers and little sign of scaled new builds, so the country is effectively locking in an import-dependent model that favors low-cost, high-consistency growers abroad. For U.S. operators hoping that federal change will open export doors, the comparison to Michigan’s tonnage and the warning about stranded MSO assets is a reminder that production cost, logistics, and reliability beat brand mythology when a medical market starts buying at industrial scale. (MMJDaily)